Vertex Form 144: Insider Files Proposed Common Stock Sales

Vertex Pharmaceuticals submitted a Form 144 notice reporting proposed sales of Common Stock by an insider.

Rhea-AI Filing Summary

Vertex Pharmaceuticals submitted a Form 144 notice reporting proposed sales of Common Stock by an insider. The filing lists multiple past transactions in the prior three months and a proposed sale routed through Fidelity Brokerage Services LLC on 05/15/2026. The sales are linked to restricted stock vesting and compensation.

Insights

Securities Compliance Counsel

Form 144 records proposed resale of vested, compensatory common shares.

The filing lists proposed sales and recent dispositions tied to restricted stock vesting and compensation. The filing names Fidelity Brokerage Services LLC as the broker and provides specific transaction dates and dollar amounts for recent sales.

Regulatory focus is procedural: ensure Rule 144 holding-period and manner-of-sale conditions are met; subsequent filings will show completion or further dispositions.

Key Figures

Proposed broker routing date: 05/15/2026 Sale reported 05/12/2026: 6988 shares, $3,144,600.00 Sales reported on other dates: 2329 shares, $1,118,641.99 (example) +1 more

4 metrics

Proposed broker routing date 05/15/2026 Fidelity Brokerage Services LLC routing date shown on the form

Sale reported 05/12/2026 6988 shares, $3,144,600.00 Disposition listed under Securities Sold During The Past 3 Months

Sales reported on other dates 2329 shares, $1,118,641.99 (example) Multiple entries dated 02/27/2026, 03/13/2026, 03/27/2026 showing 2329 and associated dollar figures

Transaction purpose Restricted Stock Vesting / Compensation Form labels linking the sales to compensation-related vesting

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"Form 144 notice reporting proposed sale of securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 02/10/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"02/10/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Vertex's (VRTX) Form 144 report show?

It reports proposed sales of Common Stock by an insider tied to restricted stock vesting. The filing lists multiple recent dispositions with dates and dollar amounts and a proposed brokerage route through Fidelity Brokerage Services LLC.

Who is identified as the seller in the VRTX Form 144?

The filing lists Carmen R. Bozic as the person associated with recent sales. The record shows her address and multiple transaction dates and amounts in the prior three months linked to compensation or vested restricted stock.

What transaction amounts are disclosed in the filing?

Recent reported sales include entries showing 2329 units with $1,118,641.99, repeated on separate dates, and a 6988 unit sale with $3,144,600.00 on 05/12/2026, as listed in the filing.

Which broker is named for the proposed resale in the filing?

The filing names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI, as the broker of record for the proposed sale routing noted with a date of 05/15/2026 on the form.

Are the reported sales described as compensation-related?

Yes. The form identifies at least one line as Restricted Stock Vesting and labels the transaction purpose as Compensation, indicating the underlying shares arose from equity awards that vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 10:41 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001790029
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Bozic Carmen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1354	613971.30	253805417	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			1354	02/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	02/27/2026	2329	1118641.99
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/13/2026	2329	1122088.91
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/27/2026	2329	1050262.55
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	05/12/2026	6988	3144600.00

144: Remarks and Signature

Remarks
Date of Notice	05/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carmen R. Bozic
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)